{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:12:40Z","timestamp":1766268760745,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology of Japan","doi-asserted-by":"crossref","award":["16K19642"],"award-info":[{"award-number":["16K19642"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology of Japan","doi-asserted-by":"crossref","award":["17H04189","19K08726"],"award-info":[{"award-number":["17H04189","19K08726"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19ek0109231h0003"],"award-info":[{"award-number":["19ek0109231h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s13730-020-00498-2","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T19:02:08Z","timestamp":1593198128000},"page":"418-422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Poststreptococcal acute glomerulonephritis can be a risk factor for accelerating kidney dysfunction in Alport syndrome: a case experience"],"prefix":"10.1007","volume":"9","author":[{"given":"Yoshinori","family":"Araki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azusa","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Nagaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Horinouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"China","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Morisada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumoto","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0290-3137","authenticated-orcid":false,"given":"Kandai","family":"Nozu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"issue":"2","key":"498_CR1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s10157-018-1629-4","volume":"23","author":"K Nozu","year":"2019","unstructured":"Nozu K, Nakanishi K, Abe Y, Udagawa T, Okada S, Okamoto T, et al. A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin Exp Nephrol. 2019;23(2):158\u201368. https:\/\/doi.org\/10.1007\/s10157-018-1629-4.","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"498_CR2","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/ki.2011.407","volume":"81","author":"O Gross","year":"2012","unstructured":"Gross O, Licht C, Anders HJ, Hoppe B, Beck B, Tonshoff B, et al. Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int. 2012;81(5):494\u2013501. https:\/\/doi.org\/10.1038\/ki.2011.407.","journal-title":"Kidney Int"},{"key":"498_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.12.015","author":"O Gross","year":"2020","unstructured":"Gross O, Tonshoff B, Weber LT, Pape L, Latta K, Fehrenbach H, et al. A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport\u2019s syndrome. Kidney Int. 2020. https:\/\/doi.org\/10.1016\/j.kint.2019.12.015.","journal-title":"Kidney Int"},{"issue":"5","key":"498_CR4","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1681\/ASN.2009070784","volume":"21","author":"MR Bekheirnia","year":"2010","unstructured":"Bekheirnia MR, Reed B, Gregory MC, McFann K, Shamshirsaz AA, Masoumi A, et al. Genotype\u2013phenotype correlation in X-linked Alport syndrome. J Am Soc Nephrol. 2010;21(5):876\u201383. https:\/\/doi.org\/10.1681\/ASN.2009070784.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"498_CR5","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/ndt\/17.7.1218","volume":"17","author":"O Gross","year":"2002","unstructured":"Gross O, Netzer KO, Lambrecht R, Seibold S, Weber M. Meta-analysis of genotype\u2013phenotype correlation in X-linked Alport syndrome: impact on clinical counselling. Nephrol Dial Transplant. 2002;17(7):1218\u201327.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"498_CR6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","volume":"11","author":"JP Jais","year":"2000","unstructured":"Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, et al. X-linked Alport syndrome: natural history in 195 families and genotype\u2013phenotype correlations in males. J Am Soc Nephrol. 2000;11(4):649\u201357.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"498_CR7","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s00467-015-3067-9","volume":"30","author":"R Lennon","year":"2015","unstructured":"Lennon R, Stuart HM, Bierzynska A, Randles MJ, Kerr B, Hillman KA, et al. Coinheritance of COL4A5 and MYO1E mutations accentuate the severity of kidney disease. Pediatr Nephrol. 2015;30(9):1459\u201365. https:\/\/doi.org\/10.1007\/s00467-015-3067-9.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"498_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/jmedgenet-2014-102822","volume":"52","author":"MA Mencarelli","year":"2015","unstructured":"Mencarelli MA, Heidet L, Storey H, van Geel M, Knebelmann B, Fallerini C, et al. Evidence of digenic inheritance in Alport syndrome. J Med Genet. 2015;52(3):163\u201374. https:\/\/doi.org\/10.1136\/jmedgenet-2014-102822.","journal-title":"J Med Genet"},{"issue":"5","key":"498_CR9","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/ki.2013.479","volume":"85","author":"Y Hashimura","year":"2014","unstructured":"Hashimura Y, Nozu K, Kaito H, Nakanishi K, Fu XJ, Ohtsubo H, et al. Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV \u03b15 chain. Kidney Int. 2014;85(5):1208\u201313. https:\/\/doi.org\/10.1038\/ki.2013.479.","journal-title":"Kidney Int"},{"issue":"5","key":"498_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/00005792-199909000-00005","volume":"78","author":"CE Kashtan","year":"1999","unstructured":"Kashtan CE. Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes. Medicine (Baltimore). 1999;78(5):338\u201360.","journal-title":"Medicine (Baltimore)."},{"issue":"3","key":"498_CR11","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000186288","volume":"57","author":"Y Hiki","year":"1991","unstructured":"Hiki Y, Tamura K, Shigematsu H, Kobayashi Y. Superimposition of poststreptococcal acute glomerulonephritis on the course of IgA nephropathy. Nephron. 1991;57(3):358\u201364. https:\/\/doi.org\/10.1159\/000186288.","journal-title":"Nephron"},{"issue":"4","key":"498_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s10157-004-0311-1","volume":"8","author":"Y Horita","year":"2004","unstructured":"Horita Y, Tadokoro M, Taura K, Suyama N, Taguchi T, Miyazaki M, et al. Histologically confirmed superimposition of post-streptococcal acute glomerulonephritis during IgA nephropathy. Clin Exp Nephrol. 2004;8(4):351\u20135. https:\/\/doi.org\/10.1007\/s10157-004-0311-1.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"498_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5414\/cnp70155","volume":"70","author":"BJ Lim","year":"2008","unstructured":"Lim BJ, Suh KS, Na KR, Lee KW, Shin YT. Acute poststreptococcal glomerulonephritis superimposed on IgA nephropathy. Clin Nephrol. 2008;70(2):155\u20138. https:\/\/doi.org\/10.5414\/cnp70155.","journal-title":"Clin Nephrol"},{"issue":"3","key":"498_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.5414\/cnp58224","volume":"58","author":"K Masutani","year":"2002","unstructured":"Masutani K, Mizumasa T, Iwanaga T, Shinozaki M, Yanagida T, Kashiwagi M, et al. Superimposition of post-streptococcal acute glomerulonephritis on the course of IgA nephropathy: predominance of Th1 type immune response. Clin Nephrol. 2002;58(3):224\u201330. https:\/\/doi.org\/10.5414\/cnp58224.","journal-title":"Clin Nephrol"},{"issue":"3","key":"498_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1442-200X.2009.02826.x","volume":"51","author":"S Fujinaga","year":"2009","unstructured":"Fujinaga S, Ohtomo Y, Mochizuki H, Murakami H, Shimizu T, Yamashiro Y, et al. Rapidly progressive acute post-streptococcal glomerulonephritis in a child with IgA nephropathy. Pediatr Int. 2009;51(3):425\u20138. https:\/\/doi.org\/10.1111\/j.1442-200X.2009.02826.x.","journal-title":"Pediatr Int"},{"issue":"6","key":"498_CR16","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/j.1442-200X.2010.03272.x","volume":"52","author":"S Fujinaga","year":"2010","unstructured":"Fujinaga S, Hirano D, Nishizaki N, Kanai H, Ohtomo Y, Kaneko K, et al. Unfavorable outcome in a child with megaureter-megacystis syndrome complicated by mild acute poststreptococcal glomerulonephritis. Pediatr Int. 2010;52(6):895\u20136. https:\/\/doi.org\/10.1111\/j.1442-200X.2010.03272.x.","journal-title":"Pediatr Int"},{"issue":"6","key":"498_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.5414\/cnp63477","volume":"63","author":"Y Naito-Yoshida","year":"2005","unstructured":"Naito-Yoshida Y, Hida M, Maruyama Y, Hori N, Awazu M. Poststreptococcal acute glomerulonephritis superimposed on bilateral renal hypoplasia. Clin Nephrol. 2005;63(6):477\u201380. https:\/\/doi.org\/10.5414\/cnp63477.","journal-title":"Clin Nephrol"},{"issue":"2","key":"498_CR18","first-page":"119","volume":"4","author":"RJ Sheridan","year":"1983","unstructured":"Sheridan RJ, Roy S 3rd, Stapleton FB. Reflux nephropathy complicated by acute post-streptococcal glomerulonephritis. Int J Pediatr Nephrol. 1983;4(2):119\u201321.","journal-title":"Int J Pediatr Nephrol"},{"issue":"9","key":"498_CR19","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3109\/0886022X.2015.1074488","volume":"37","author":"V Tasic","year":"2015","unstructured":"Tasic V, Ristoska-Bojkovska N, Gucev Z, Lozanovski VJ. Poststreptococcal glomerulonephritis in children with congenital anomalies of the kidney and urinary tract. Ren Fail. 2015;37(9):1440\u20133. https:\/\/doi.org\/10.3109\/0886022X.2015.1074488.","journal-title":"Ren Fail"},{"key":"498_CR20","volume-title":"StatPearls","author":"P Rawla","year":"2020","unstructured":"Rawla P, Padala SA, Ludhwani D. Poststreptococcal Glomerulonephritis. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2020."},{"issue":"1","key":"498_CR21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1186\/s12882-019-1663-9","volume":"20","author":"K Yano","year":"2019","unstructured":"Yano K, Suzuki H, Oda T, Ueda Y, Tsukamoto T, Muso E. Crescentic poststreptococcal acute glomerulonephritis accompanied by small vessel vasculitis: case report of an elderly male. BMC Nephrol. 2019;20(1):471. https:\/\/doi.org\/10.1186\/s12882-019-1663-9.","journal-title":"BMC Nephrol"},{"key":"498_CR22","doi-asserted-by":"publisher","first-page":"CD004406","DOI":"10.1002\/14651858.CD004406.pub3","volume":"4","author":"ML van Driel","year":"2013","unstructured":"van Driel ML, De Sutter AI, Keber N, Habraken H, Christiaens T. Different antibiotic treatments for group A streptococcal pharyngitis. Cochrane Database Syst Rev. 2013;4:CD004406. https:\/\/doi.org\/10.1002\/14651858.CD004406.pub3.","journal-title":"Cochrane Database Syst Rev."},{"issue":"4","key":"498_CR23","doi-asserted-by":"publisher","first-page":"ofz097","DOI":"10.1093\/ofid\/ofz097","volume":"6","author":"AP Ralph","year":"2019","unstructured":"Ralph AP, Holt DC, Islam S, Osowicki J, Carroll DE, Tong SYC, et al. Potential for molecular testing for group A streptococcus to improve diagnosis and management in a high-risk population: a prospective study. Open Forum Infect Dis. 2019;6(4):ofz097. https:\/\/doi.org\/10.1093\/ofid\/ofz097.","journal-title":"Open Forum Infect Dis."},{"issue":"4","key":"498_CR24","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2215\/CJN.14021118","volume":"14","author":"C Tomson","year":"2019","unstructured":"Tomson C, Tomlinson LA. Stopping RAS Inhibitors to minimize AKI: more harm than good? Clin J Am Soc Nephrol. 2019;14(4):617\u20139. https:\/\/doi.org\/10.2215\/CJN.14021118.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00498-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-020-00498-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-020-00498-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T23:11:29Z","timestamp":1624662689000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-020-00498-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["498"],"URL":"https:\/\/doi.org\/10.1007\/s13730-020-00498-2","relation":{},"ISSN":["2192-4449"],"issn-type":[{"type":"electronic","value":"2192-4449"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"assertion":[{"value":"14 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was supported by the Grants-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (subject ID: 16K19642 to Tomohiko Yamamura and 17H04189 to Kazumoto Iijima, and 19K08726 to Kandai Nozu) and by the Japan Agency for Medical Research and Development (AMED) (Grant number JP19ek0109231h0003 to Kazumoto Iijima and Kandai Nozu).Kandai Nozu and Kazumoto Iijima have filed a patent application on the development of antisense nucleotides for exon skipping therapy in Alport syndrome.Kazumoto Iijima has received grant support from Daiichi Sankyo Co., Ltd.; consulting fees from Kyowa Kirin Co., Ltd., and Boehringer Ingelheim; and lecture fees from Kyowa Kirin Co., Ltd., Chugai Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company, Integrated Development Associates, and Novartis Pharmaceuticals Corporation.Kandai Nozu has received consulting fees from Kyowa Kirin Co., Ltd.; and lecture fees from Kyowa Kirin Co., Ltd., Novartis Pharmaceuticals Corporation, and Chugai Pharmaceutical Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No information identifying the individual patient is published, and personal information is protected. The patient, his parents, and his grandmother provided informed consent for the publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee at which the studies were conducted (IRB approval number 301) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This article does not describe any studies with human participants or animals performed by any of the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}}]}}